U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07174245) titled 'Pregnancy and Postpartum CGM in GDM' on Sept. 08.
Brief Summary: Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.
Study Start Date: Aug. 05
Study Type: OBSERVATIONAL
Conditio...